Yoshimi Kikuchi

6.0k total citations · 1 hit paper
170 papers, 4.3k citations indexed

About

Yoshimi Kikuchi is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Yoshimi Kikuchi has authored 170 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Infectious Diseases, 60 papers in Epidemiology and 41 papers in Virology. Recurrent topics in Yoshimi Kikuchi's work include HIV/AIDS drug development and treatment (50 papers), HIV Research and Treatment (41 papers) and HIV/AIDS Research and Interventions (28 papers). Yoshimi Kikuchi is often cited by papers focused on HIV/AIDS drug development and treatment (50 papers), HIV Research and Treatment (41 papers) and HIV/AIDS Research and Interventions (28 papers). Yoshimi Kikuchi collaborates with scholars based in Japan, United States and United Kingdom. Yoshimi Kikuchi's co-authors include K. Yokoyama, Shinichi Oka, Hiroyuki Gatanaga, Noriki Nio, Katsuji Teruya, Takeshi Nishijima, Masayo Date, Hiroshi Matsui, Shigeki Mizuno and Kunihisa Tsukada and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Yoshimi Kikuchi

170 papers receiving 4.2k citations

Hit Papers

Properties and applications of microbial transglutaminase 2004 2026 2011 2018 2004 100 200 300 400

Peers

Yoshimi Kikuchi
David H. Dockrell United Kingdom
Pierre Michetti Switzerland
Peter H. Nibbering Netherlands
John H. Eldridge United States
Lisa C. Rohan United States
Eva Medina Germany
David H. Dockrell United Kingdom
Yoshimi Kikuchi
Citations per year, relative to Yoshimi Kikuchi Yoshimi Kikuchi (= 1×) peers David H. Dockrell

Countries citing papers authored by Yoshimi Kikuchi

Since Specialization
Citations

This map shows the geographic impact of Yoshimi Kikuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Kikuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Kikuchi more than expected).

Fields of papers citing papers by Yoshimi Kikuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Kikuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Kikuchi. The network helps show where Yoshimi Kikuchi may publish in the future.

Co-authorship network of co-authors of Yoshimi Kikuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Kikuchi. A scholar is included among the top collaborators of Yoshimi Kikuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Kikuchi. Yoshimi Kikuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mizushima, Daisuke, et al.. (2023). Effect of unintended short-term 3.0 g/day amoxicillin and probenecid treatment for early syphilis on patients with HIV-1 infection. Therapeutic Advances in Infectious Disease. 10. 2018427593–2018427593. 1 indexed citations
2.
Mizushima, Daisuke, Misao Takano, Takahiro Aoki, et al.. (2023). Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men. Hepatology. 77(6). 2084–2092. 11 indexed citations
3.
Yanagawa, Yasuaki, Misao Takano, Takahiro Aoki, et al.. (2022). Identification of asymptomatic Entamoeba histolytica infection by a serological screening test: A cross-sectional study of an HIV-negative men who have sex with men cohort in Japan. PLoS neglected tropical diseases. 16(4). e0009793–e0009793. 6 indexed citations
4.
Kondo, Kenji, Masayoshi Kobayashi, Kazutaka Shimbo, et al.. (2022). Lipocalin 15 in the olfactory mucus is a biomarker for Bowman’s gland activity. Scientific Reports. 12(1). 9984–9984. 6 indexed citations
5.
Imai, Koubun, Aki Watanabe, Ei Kinai, et al.. (2020). Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients. PLoS ONE. 15(3). e0230292–e0230292. 2 indexed citations
6.
Yanagawa, Yasuaki, Mami Nagashima, Hiroyuki Gatanaga, et al.. (2020). Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study. BMJ Open. 10(2). e031605–e031605. 8 indexed citations
7.
Mizushima, Daisuke, Misao Takano, Haruka Uemura, et al.. (2019). High prevalence and incidence of rectal Chlamydia infection among men who have sex with men in Japan. PLoS ONE. 14(12). e0220072–e0220072. 13 indexed citations
8.
Takano, Misao, et al.. (2018). Assessment of HIV prevalence among MSM in Tokyo using self-collected dried blood spots delivered through the postal service. BMC Infectious Diseases. 18(1). 627–627. 26 indexed citations
10.
Tsuboi, Motoyuki, Takeshi Nishijima, Shigeko Yashiro, et al.. (2016). Prognosis of ocular syphilis in patients infected with HIV in the antiretroviral therapy era. Sexually Transmitted Infections. 92(8). 605–610. 35 indexed citations
11.
Nishijima, Takeshi, Hiroyuki Gatanaga, Katsuji Teruya, et al.. (2014). Brain Magnetic Resonance Imaging Screening Is Not Useful for HIV-1-Infected Patients Without Neurological Symptoms. AIDS Research and Human Retroviruses. 30(10). 970–974. 7 indexed citations
12.
Hamada, Yohei, Takeshi Nishijima, Hirokazu Komatsu, et al.. (2013). Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?. PLoS ONE. 8(7). e69845–e69845. 9 indexed citations
13.
Nishijima, Takeshi, Yohei Hamada, Kôji Watanabe, et al.. (2013). Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients. PLoS ONE. 8(10). e77268–e77268. 17 indexed citations
14.
Mizushima, Daisuke, Takeshi Nishijima, Hiroyuki Gatanaga, et al.. (2013). Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naïve Patients with Advanced HIV-1 Infection in the HAART Era. PLoS ONE. 8(5). e65348–e65348. 12 indexed citations
15.
Hamada, Yohei, Naoyoshi Nagata, Takuro Shimbo, et al.. (2013). Assessment of Antigenemia Assay for the Diagnosis of Cytomegalovirus Gastrointestinal Diseases in HIV-Infected Patients. AIDS Patient Care and STDs. 27(7). 387–391. 6 indexed citations
16.
Gatanaga, Hiroyuki, Natsuo Tachikawa, Yoshimi Kikuchi, et al.. (2006). Urinary β 2 -Microglobulin as a Possible Sensitive Marker for Renal Injury Caused by Tenofovir Disoproxil Fumarate. AIDS Research and Human Retroviruses. 22(8). 744–748. 81 indexed citations
17.
Yamamoto, Yoshihiko, Akira Yasuoka, Katsuji Teruya, et al.. (2001). Leukocytopenia Due to Zidovudine- and Nevirapine-Containing Regimens in Elderly Patients with HIV Infection. Japanese Journal of Infectious Diseases. 53(6). 244–245. 4 indexed citations
18.
19.
Yamamoto, Yoshihiko, Akira Yasuoka, Natsuo Tachikawa, et al.. (2000). Mitigation of Hepato-Cellular Injury Caused by HAART with Glycyrrhizin Compound in Patients Co-Infected with HIV and HCV. Japanese Journal of Infectious Diseases. 52(6). 248–249. 6 indexed citations
20.
Kikuchi, Yoshimi, Shinichi Oka, Mieko Goto, et al.. (1991). A Case of Human-Immunodeficiency Virus Infection Related Mycobacterium tuberculosis with Atypical Clinical Features. Kansenshogaku zasshi. 65(7). 888–892. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026